CIS
CVS icon

Capital International Sarl’s CVS Health CVS Stock Holding History

Capital International Sarl’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.35M Sell
90,383
-1,832
-2% -$164K 0.13% 120
2026
Q1 		$6.62M Buy
92,215
+16,984
+23% +$1.31M 0.11% 128
2025
Q4 		$5.97M Buy
75,231
+1,929
+3% +$152K 0.1% 140
2025
Q3 		$5.53M Buy
73,302
+700
+1% +$48K 0.1% 140
2025
Q2 		$5.01M Sell
72,602
-6,940
-9% -$455K 0.1% 143
2025
Q1 		$5.39M Buy
79,542
+32,391
+69% +$1.94M 0.12% 130
2024
Q4 		$2.12M Buy
47,151
+20,306
+76% +$1.14M 0.05% 183
2024
Q3 		$1.69M Buy
26,845
+9,213
+52% +$537K 0.04% 186
2024
Q2 		$1.04M Sell
17,632
-15,419
-47% -$965K 0.03% 208
2024
Q1 		$2.64M Buy
33,051
+12,852
+64% +$982K 0.09% 166
2023
Q4 		$1.59M Buy
+20,199
New +$1.44M 0.06% 193

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Sarl's CVS Position: Q2 2026 in Review

Capital International Sarl reduced its CVS Health (CVS) stake by 2% in Q2 2026, selling an estimated $164K and leaving 90,383 shares worth $9.35M. The position accounts for 0.13% of the portfolio, ranked #120.

Capital International Sarl first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Capital International Sarl held 90,383 shares of CVS Health worth $9.35M as of Q2 2026.
  • Capital International Sarl sold 1,832 CVS Health shares in Q2 2026, an estimated $164K.
  • CVS Health made up 0.13% of Capital International Sarl's portfolio in Q2 2026, its #120 holding.
  • Capital International Sarl first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.